Chomobacterium violaceum is a gram-negative bacteria, which inhabit soil or water and rarely causes disease in human. The first case of C. violaceum bacteria isolated from a 6-month-old male admitted at Muhimbili National Hospital, Tanzania, is reported. A patient had a high fever (39.2°C), vomiting with no history of convulsion, loss of consciousness, skin or joint infection, cough or difficulty in breathing, neither ear pain nor ear discharge. On admission, blood examination found no malaria parasites with normal urinalysis. Venous blood samples were taken for blood culture followed by empirical therapy with ceftriaxone 800 mg daily, intravenous paracetamol 125 mg stat then 125 mg 8 hourly was initiated. On the second day post-admission, the patient succumbed to septic shock before blood culture results were available. In conclusion, cultural and biochemical identification of a blood culture revealed C. violaceum infection.
Introduction
A Chromobacterium violaceum is a large, motile, gramnegative bacillus and facultative anaerobic bacteria [1] . The bacteria commonly inhabit the soil and water in tropical and subtropical regions [2] and rarely cause disease in humans [1, 2] , i.e., about 150 documented cases globally [3] [4] [5] . C. violaceum resembles members of family enterobacteriaceae by many common identification methods [2] . But unlike Klebsiellaceae, Chromobacterium produces violet, alcohol-soluble, water-insoluble pigment, violacein, Serratia produces an alcohol-soluble, slightly water-soluble red or yellow pigment, prodigiosin, and Pseudomonas species produce the water-soluble pigment, fluorescein [2] .
The bacteria enter the human body through injured skin coming in contact with soil or water containing the bacteria [2] [3] [4] . The disease starts as a skin infection, which may progress to necrotizing metastatic lesions, then multiple abscesses of the organs leading to fatal severe septicemia caused by multi-organ failure [5, 6] . We therefore, report the first case of C. violaceum isolated from a blood of a 6-month-old Tanzanian patient. consciousness, and skin or joint infection and with a difficult in breastfeeding. There was no cough or difficulty in breathing, neither ear pain nor ear discharge was reported. The patient had no history of diarrhea or underlying problem and micturition was found normal. On admission, a child had no emergence sign, febrile at 39.2 o C, anemic (hemoglobin level less than 6.0 g/dl), there were no cyanotic, palpable lymph nodes, and he was not dehydrated. The child's weight was 8.7 kg, length was 68.5 cm, and mid-upper-arm circumference was 12.4 cm. Pulse rate was 102 beats/min, respiratory rate was 54 breaths/min, extremities were warm, and some pallor was noted with no jaundice. Cardiovascular examination revealed normal heart sounds with no murmur, respiratory examination revealed vesicular breathe sounds with no added sounds, and abdominal examination revealed normal findings.
Both rapid malaria diagnostic test and blood slide microscopy had no malaria parasite, and urinalysis was normal. Some aspects of complete blood count revealed white blood cells (WBC); 51.6 × 10 3 /μL, neutrophil; 43.4 × 10 3 /μL (83.4%), monocytes; 5.14x 10 3 /μL (9.96%), lymphocytes; 3.03x10 3 / μL (5.87%), hemoglobin level; 8.09 g/dL and platelet; and 150 x10 3 /μL (100-550). Serum electrolyte and ions were all in normal ranges. Creatinine was 42.6 μmol/L; serology screening for human immunodeficiency virus (HIV), hepatitis A, B, and hepatitis C virus tested negative. Blood samples for culture were drawn on the first day of admission before initiation of empirical antibiotic treatment.
Therapeutic Interventions
In the ward, the patient was given ceftriaxone 800 mg daily for 10 days (received 3 doses), intravenous paracetamol 125 mg stat then patient continued with tablets 125 mg 8 hourly for 3 days. Vomiting stopped on the first day of admission.
On a second day, child's body temperature ranged 38.6-39 o C (measured 4 hourly). On a 3rd day, child became weak, unable to suck, and continued to have fever. On examination, child was lethargic with Glasgow Coma Scale (GCS) of 12/15 (Eye 3, verbal 4, motor 5) severe pallor, warm extremities with good capillary refill time < 3 sec, had generalized skin rashes, hyperemic measuring 0.1x0.1 cm, flat surface no pus non tender [7] . Child was not jaundiced, not cyanotic. Body temperature 38.2 o C, with a pulse rate of 106 beats/min and a respiratory rate of 69 breaths/min had lower chest wall in drawing, vesicular breathing sound with no added sound. Blood oxygen saturation was 100% at room air. Random blood glucose was 6.3mmo/diagnosis of severe anemia (not in failure) secondary to septicemia was made. Complete blood count was repeated and showed moderate microcytic hypo chromic anemia of hemoglobin 6.87 g/dl, leukocytosis [WBCs (white blood cells) 44,000cells/mm 3 ] predominant neutrophil (89.9%) lymphocyte was 2.90%. There were normal RBCs (red blood cells), platelet, and peripheral smear. Had C reactive protein 355 mg/L with features of iron deficiency anemia. Electrolytes, liver, and renal function test were found to be normal [8] .
He was transfused 87 ml of packed red blood cell, nasogastric tube for feeding and he continued with ceftriaxone injection and paracetamol tablets, 3 h later baby condition become worse had poor capillary refill time > 3 sec, cold extremities, pulse rate; 157b/min with blood pressure 65/52 mmHg, respiratory rate; 63 breath/min, blood oxygen saturation was 89% at room air, temperature was 37.8 o C, random blood glucose was 5.2 mml/L. We managed as case of septic shock and provision of oxygen therapy [8] ; however, the patient succumbed to death 55 h after admission before blood culture result.
Microbiological Investigations
Blood Culture
Blood sampling and culture were performed according to MNH-Central pathology laboratory (CPL) protocol (not published). Briefly, multiple blood samples were collected from different veins of the patient before initiation of ceftriaxone. Samples were immediately incubated into BD™ Bactec™ FX40 incubator (Fischer Scientific, USA) within 24 h; the blood culture indicated the presence of organism. On the same day (first day of admission), gram stain smear was performed and showed gram-negative bacillus then samples were inoculated on nutrient agar, blood agar, and MacConkey agar (MCA) and incubated aerobically at 37°C for 24 h. On 3rd day post admission, smooth, round, convex, violet-colored colonies were observed in all three-culture plates ( Fig. 1a and b, MCA not shown). Additionally, beta-hemolysis was seen on blood agar plates (Fig. 1a ).
Biochemical Identification
The biochemical identification was performed using analytical profile index for enterobacteriaceae (APi20E) APIWEB™ (online bacteria and yeast database) (BioMérieux, USA) at Muhimbili University of Health and Allied Science, Bacteriology Lab. The organism was a facultative anaerobic, motile, and gram-negative rod. Furthermore, organism was both catalase and oxidase positive. Biochemically, indole was positive while methyl red and Voges-Proskauer test were negative. The organism fermented glucose (producing acid but no gas) and trehalose but did not ferment lactose or mannitol. Kligler Iron Agar medium showed an alkaline slant (K) and acid butt (A) (K/A) without gas and H 2 S production. Citrate was utilized and nitrate was reduced. Arginine was hydrolyzed but not lysine and ornithine (Fig. 2) .
Antibiotic Susceptibility
Antibiotic susceptibility test (AST) of the isolated C. violaceum was performed on Muller-Hinton agar by Kirby-Bauer disc diffusion method. Five antibiotic discs were selected as per MNH lab protocol (unpublished) while AST procedures were performed as recommended by National Committee for Clinical Laboratory Standards (NCCLS) [9] . The bacterium was found to be sensitive to ciprofloxacin, amikacin, and tobramycin but resistant to cefuroxime and imepenem.
Discussion
In the recent years, there has been an increase in reported cases of C. violaceum infection in human, i.e., 5% of neonatal septicaemia in Calabar, Nigeria, were due to C. violaceum [1] . To the best of our knowledge, we report the first case caused by C. violaceum from a Tanzanian clinical isolate. The biochemical reaction (APi20E) was performed and identified the isolate as C. violaceum; these findings were similar to those already described elsewhere [9] [10] [11] [12] . The large raised round colonies with a dark violet metallic sheen concur to the findings by Sippel et al [13] . Surprisingly, pigmentation on Muller-Hinton agar a medium commonly used for antibiotics susceptibility test was also noted in the current isolate.
The organism from our case was isolated from blood of a child with no history of wound or skin infection whereas the report of fatal septicemia from Argentina, organism was isolated from the skin lesion [6] . However, the current case was comparable to that from Florida, USA, where the source of infection was found to be non-skin [14] .
On other hand, the route and source of infection in our case is unknown, a report by Sippel et al., which found cervical adenitis in swine infected through the oral route [13] , suggesting that routes of infection other than skin wounds are possible. The source of infection in the current case was thought to have been from water or soil; however the child was exclusively breastfeeding. In addition to that, evidence from the case reported from Florida, USA, failed to find the correlation between soil and water specimens from around the patient's home to those from clinical isolate [14] .
Regarding the patient's management, the patient was empirically given ceftriaxone 800 mg daily for 10 days (received 3 doses), intravenous paracetamol 125 mg stat, then patient continued with tablets 125 mg 8 hourly for 3 days as recommended by standard treatment guideline [8] .
The organism was found to be sensitive to ciprofloxacin, amikacin, and tobramycin but resistant to cefuroxime and imepenem while ceftriaxone was not tested. Evidence from a review by Sayomporn et al. [15] indicated that all successfully treated cases received 1 or a combination of ciprofloxacin, trimethroprim-sulfamethoxazole, chloramphenicol, or imipenem, and the review considered them as effective drugs. A penicillin or cephalosporin with or without an aminoglycoside was the initial therapy in 15 cases without improvement; 6 died and the drugs were changed in the 9 surviving cases to 1 or a combination of effective drug.
Moreover, Guo et al., 2017 [16] reported the case of C. violaceum infection in a 12-month-old girl without any known history of immunodeficiency. The patient developed fever with redness and swelling over the middle phalanx of the a b Fig. 1 Cultural properties of C. violaceum on blood agar ( Fig.  1a ) and nutrient agar (Fig. 1b) .
Smooth, round, convex, violetcolored colonies were noticed on blood agar (Fig. 1a ), nutrient agar ( Fig. 1b) . On blood agar, deep violet colonies with betahemolysis were seen (Fig. 1a ) Fig. 2 APi20E biochemical test strip. Identified the bacterium as Chomobacterium violaceum right hand index finger, which progressed to the formation of skin abscess. After intravenous meropenem and surgical drainage of the skin abscess, the patient was cured. A review indicated that fever (100%), sepsis (82%), skin lesions (67.9%), and abdominal pain (31.1%) were the most leading clinical manifestations where about fifty-six patients (53%) were dead. Almost all of the penicillin, ampicillin, and firstand second-generation cephalosporins exhibited totally resistant to C. violaceum [17] . Identification of C. violaceum was limited to cultural properties and biochemical identification. Blood culture results found a child already died which limited more laboratory investigations. Moreover, most cases have been associated with immune deficiencies [mostly chronic granulomatous disease (CGD) and glucose-6-phosphate dehydrogenase (G6PD)] [5] , but the patient died before full bacteriological confirmation and no immune evaluation could be done.
Conclusions
Microbiological investigations of blood culture revealed C. violaceum infection. The patient was treated with ceftriaxone according to local guidelines and died before specific changes could be made based on susceptibility report. Lastly, since C. violaceum is a soil saprophytic bacterium and water inhabitant and rarely cause disease in human, care must be taken not to incorrectly diagnose it as a contaminant.
